Last €91.59 EUR
Change Today +0.087 / 0.10%
Volume 35.1K
NOT On Other Exchanges
Symbol
Exchange
New York
OTC US
Mexico
SIX Swiss Ex
SIX Swiss Ex
Frankfurt
As of 1:16 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by NOVARTIS AG-REG (NOT) in the last 6 months

Announced 01/7/15
Caribou Biosciences, Inc.
Private Placement

Caribou Biosciences, Inc. announced that it has received undisclosed amount in series A round of equity funding from Novartis AG on January 7, 2015.


NOT's price was unchanged after the transaction was announced on 01/7/15.
Investor / Buyer
Novartis AG
 
Announced 11/18/14
15.00M for Intellia Therapeutics Inc.
Private Placement

Intellia Therapeutics announced that it has received $15 million in its first round of funding from new investors Atlas Venture L.P. and the research arm of Novartis AG. on November 18, 2014. Atlas Venture L.P. invested in the formation of the company.


NOT's price was unchanged after the transaction was announced on 11/18/14.
Investor / Buyer
Atlas Venture L.P.
Novartis AG
 
Announced 10/26/14
275.00M for Novartis AG, Influenza Vaccines Business
Merger/Acquisition

bioCSL Inc. entered into a definitive agreement to acquire influenza vaccines business from Novartis AG (SWX:NOVN) for approximately $280 million on October 26, 2014. The Novartis influenza vaccines unit will be combined with bioCSL. For the year ended December 31, 2013, influenza vaccines business posted sales of $527 million. The transaction requires regulatory approvals and is expected to close in the second half of 2015. Tim Duncan of Hintons & Associates acted as ...
Read More


NOT's price was unchanged after the transaction was announced on 10/26/14.
Investor / Buyer
bioCSL Inc.
Creditor / Lender
Novartis AG
 
Announced 10/14/14
24.00M for Raze Therapeutics, Inc.
Private Placement

Raze Therapeutics announced that it has received $24 million in its series A round of funding on October 14, 2014. The transaction included participation from new investors, Atlas Venture L.P., MPM Capital, Merck Serono S.A., Investment Arm, Partners Innovation Fund, Astellas Venture Management LLC, and Novartis AG. As part of the round, Ansbert Gadicke of MPM Capital, Nilesh Kumar of Merck Serono S.A., Investment Arm, Reza Halse of Partners Innovation Fund, Jason Rhodes ...
Read More


NOT's price was unchanged after the transaction was announced on 10/14/14.
Investor / Buyer
Astellas Venture Management LLC
Atlas Venture L.P.
Merck Serono S.A., Investment Arm
MPM Capital
Novartis AG
Partners Innovation Fund
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOT:GR €91.59 EUR +0.087

NOT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $103.64 USD -0.55
Johnson & Johnson $102.54 USD -0.26
Merck & Co Inc $58.54 USD -0.42
Pfizer Inc $34.34 USD -0.25
Roche Holding AG SFr.258.80 CHF -0.20
View Industry Companies
 

Industry Analysis

NOT

Industry Average

Valuation NOT Industry Range
Price/Earnings 23.8x
Price/Sales 4.6x
Price/Book 3.5x
Price/Cash Flow 27.2x
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.